blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2704751

EP2704751 - ULTRAFILTRATION CONCENTRATION OF ALLOTYPE SELECTED ANTIBODIES FOR SMALL-VOLUME ADMINISTRATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.02.2020
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  15.03.2019
FormerGrant of patent is intended
Status updated on  22.10.2018
FormerExamination is in progress
Status updated on  02.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Immunomedics, Inc.
300 American Road
Morris Plains, NJ 07950 / US
[2014/11]
Inventor(s)01 / ZENG, Li
300 American Road
Morris Plains New Jersey 07950 / US
02 / MITRA, Rohini
300 American Road
Morris Plains New Jersey 07950 / US
03 / ROSSI, Edmund A.
300 American Road
Morris Plains New Jersey 07950 / US
04 / HANSEN, Hans J.
300 American Road
Morris Plains New Jersey 07950 / US
05 / GOLDENBERG, David M.
300 American Road
Morris Plains New Jersey 07950 / US
 [2014/11]
Representative(s)Bohmann, Armin K.
Bohmann
Anwaltssozietät
Nymphenburger Straße 1
80335 München / DE
[2019/16]
Former [2014/11]Bohmann, Armin K.
bohmann Anwaltssozietät Nymphenburger Strasse 1
80335 München / DE
Application number, filing date12779847.801.05.2012
[2019/16]
WO2012US35980
Priority number, dateUS201161481489P02.05.2011         Original published format: US 201161481489 P
US201161509850P20.07.2011         Original published format: US 201161509850 P
[2014/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012151199
Date:08.11.2012
Language:EN
[2012/45]
Type: A1 Application with search report 
No.:EP2704751
Date:12.03.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 08.11.2012 takes the place of the publication of the European patent application.
[2014/11]
Type: B1 Patent specification 
No.:EP2704751
Date:17.04.2019
Language:EN
[2019/16]
Search report(s)International search report - published on:US08.11.2012
(Supplementary) European search report - dispatched on:EP07.05.2015
ClassificationIPC:A61K39/395, C07K16/00, C07K16/06, C07K16/28, C07K16/30, C07K16/46
[2018/43]
CPC:
A61K39/39591 (EP,CN,US); C07K16/2851 (CN,US); A61K39/3955 (EP,US);
A61K45/06 (EP,US); A61K47/6849 (EP,US); A61K47/6869 (EP,US);
A61K47/6879 (EP,US); A61K47/6897 (EP,US); A61K51/088 (EP,CN,US);
A61K51/1027 (US); A61K51/1045 (US); A61K9/0019 (US);
A61K9/08 (US); A61P25/00 (EP); A61P25/28 (EP);
A61P3/00 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P9/00 (EP);
A61P9/10 (EP); B82Y5/00 (EP,CN,US); C07K16/065 (EP,CN,US);
C07K16/2803 (EP,CN,US); C07K16/2833 (EP,CN,US); C07K16/2887 (EP,CN,US);
C07K16/2896 (CN,US); C07K16/30 (EP,CN,US); C07K16/3007 (US);
C07K16/3069 (CN,US); C07K16/3092 (US); A61K2039/505 (EP,CN,US);
A61K2039/54 (US); A61K2039/545 (US); A61K2039/55505 (US);
A61K2039/55511 (US); C07K2317/24 (EP,CN,US); C07K2317/31 (EP,CN,US);
C07K2317/51 (CN,US); C07K2317/515 (CN,US); C07K2317/52 (EP,CN,US);
C07K2317/56 (CN,US); C07K2317/94 (CN,US) (-)
Former IPC [2015/01]A61K51/10, A61K39/00, A61K39/395, A61K47/48, B82Y5/00, C07K16/00, C07K16/06, C07K16/28, C07K16/30, C07K16/46
Former IPC [2014/11]A61K51/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/11]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ULTRAFILTRATIONSKONZENTRATION AUSGEWÄHLTER ALLOTYPEN-ANTIKÖRPER FÜR KLEINVOLUMIGE VERABREICHUNG[2014/11]
English:ULTRAFILTRATION CONCENTRATION OF ALLOTYPE SELECTED ANTIBODIES FOR SMALL-VOLUME ADMINISTRATION[2014/11]
French:CONCENTRATION D'ULTRAFILTRATION D'ANTICORPS À ALLOTYPE SÉLECTIONNÉ POUR UNE ADMINISTRATION DE PETIT VOLUME[2014/11]
Entry into regional phase15.10.2013National basic fee paid 
15.10.2013Search fee paid 
15.10.2013Designation fee(s) paid 
15.10.2013Examination fee paid 
Examination procedure15.10.2013Examination requested  [2014/11]
15.01.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
29.03.2016Amendment by applicant (claims and/or description)
21.06.2016Despatch of a communication from the examining division (Time limit: M06)
02.01.2017Reply to a communication from the examining division
19.03.2018Cancellation of oral proceeding that was planned for 21.03.2018
21.03.2018Date of oral proceedings (cancelled)
27.03.2018Despatch of a communication from the examining division (Time limit: M02)
06.06.2018Reply to a communication from the examining division
23.10.2018Communication of intention to grant the patent
04.03.2019Fee for grant paid
04.03.2019Fee for publishing/printing paid
04.03.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.06.2016
Opposition(s)20.01.2020No opposition filed within time limit [2020/13]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
29.03.2016Request for further processing filed
29.03.2016Full payment received (date of receipt of payment)
Request granted
18.04.2016Decision despatched
Fees paidRenewal fee
28.02.2014Renewal fee patent year 03
21.05.2015Renewal fee patent year 04
20.05.2016Renewal fee patent year 05
23.05.2017Renewal fee patent year 06
25.05.2018Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.05.2012
AL17.04.2019
AT17.04.2019
CY17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
MK17.04.2019
MT17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SI17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
IE01.05.2019
LU01.05.2019
BE31.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
[2022/31]
Former [2021/34]HU01.05.2012
AL17.04.2019
AT17.04.2019
CY17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
MT17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SI17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
IE01.05.2019
LU01.05.2019
BE31.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2021/33]HU01.05.2012
AL17.04.2019
AT17.04.2019
CY17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SI17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
IE01.05.2019
LU01.05.2019
BE31.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2021/26]AL17.04.2019
AT17.04.2019
CY17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SI17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
IE01.05.2019
LU01.05.2019
BE31.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/26]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SI17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
IE01.05.2019
LU01.05.2019
BE31.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/21]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
IE01.05.2019
LU01.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/17]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SK17.04.2019
SM17.04.2019
TR17.04.2019
LU01.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/13]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SK17.04.2019
SM17.04.2019
LU01.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/12]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
IT17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SK17.04.2019
LU01.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/11]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
EE17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
SK17.04.2019
LU01.05.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/10]AL17.04.2019
AT17.04.2019
CZ17.04.2019
DK17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RO17.04.2019
RS17.04.2019
SE17.04.2019
CH31.05.2019
LI31.05.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/09]AL17.04.2019
CZ17.04.2019
DK17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RS17.04.2019
SE17.04.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/08]AL17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
MC17.04.2019
NL17.04.2019
PL17.04.2019
RS17.04.2019
SE17.04.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2020/04]AL17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
NL17.04.2019
PL17.04.2019
RS17.04.2019
SE17.04.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
IS17.08.2019
PT17.08.2019
Former [2019/52]AL17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
NL17.04.2019
PL17.04.2019
RS17.04.2019
SE17.04.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
PT17.08.2019
Former [2019/51]AL17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
NL17.04.2019
RS17.04.2019
SE17.04.2019
BG17.07.2019
NO17.07.2019
GR18.07.2019
PT17.08.2019
Former [2019/50]AL17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
LV17.04.2019
NL17.04.2019
RS17.04.2019
SE17.04.2019
NO17.07.2019
GR18.07.2019
PT17.08.2019
Former [2019/49]AL17.04.2019
ES17.04.2019
FI17.04.2019
HR17.04.2019
LT17.04.2019
NL17.04.2019
SE17.04.2019
NO17.07.2019
PT17.08.2019
Former [2019/48]ES17.04.2019
FI17.04.2019
LT17.04.2019
NL17.04.2019
SE17.04.2019
NO17.07.2019
PT17.08.2019
Former [2019/47]ES17.04.2019
FI17.04.2019
LT17.04.2019
NL17.04.2019
NO17.07.2019
Former [2019/44]NL17.04.2019
Documents cited:Search[XYI]WO2007103469  (AERES BIOMEDICAL LTD [GB], et al) [X] 1,2,8,10,12-14 * paragraphs [[0288]] , [[0289]] * [Y] 3 [I] 4-7,9,11;
 [XYI]WO2008137915  (MEDIMMUNE LLC [US], et al) [X] 1,2,8,10,12-14 * paragraphs [[0384]] , [[0385]] * [Y] 3 [I] 4-7,9,11;
 [Y]WO2009006301  (BATTELLE MEMORIAL INSTITUTE [US], et al) [Y] 3 * tables 5-9 *;
 [XYI]  - Abbott, "HUMIRA", US, USA, (20030131), pages 1 - 13, URL: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3930B1_02_B-Abbott-Humira Prescribing Info.pdf, (20140320), XP055109061 [X] 1,2,8,10,12-14 * page 1 * [Y] 3 [I] 4-7,9,11
 [Y]  - GOLOVANOV A P ET AL, "A simple method for improving protein solubility and long-term stability", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, vol. 126, no. 29, doi:10.1021/JA049297H, ISSN 0002-7863, (20040728), pages 8933 - 8939, (20040701), XP002686711 [Y] 3 * table 1 *

DOI:   http://dx.doi.org/10.1021/ja049297h
 [A]  - ROY JEFFERIS ET AL, "Human immunoglobulin allotypes", MABS, (20090101), vol. 1, no. 4, pages 1 - 7, XP055096625 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.4161/mabs.1.4.9122
 [T]  - PRISCILLA KHEDDO ET AL, "The effect of arginine glutamate on the stability of monoclonal antibodies in solution", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (20141001), vol. 473, no. 1-2, doi:10.1016/j.ijpharm.2014.06.053, ISSN 0378-5173, pages 126 - 133, XP055151603 [T] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ijpharm.2014.06.053
International search[Y]US2003004094  (GHOSE SANCHAYITA [US], et al);
 [Y]US2004033561  (O'KEEFE THERESA L [US], et al);
 [X]US2004208870  (ALLAN CHRISTIAN B [US]);
 [X]US2006153846  (KRAUSE HANS-JUERGEN [DE], et al);
 [Y]US7151164  (HANSEN HANS [US], et al);
 [Y]US2007258981  (HILBERT DAVID M [US], et al);
 [Y]WO2008028946  (CRUCELL HOLLAND BV [NL], et al);
 [Y]US2008306247  (MIZUSHIMA HIDEFUMI [JP], et al);
 [Y]US2009117111  (AUKERMAN SHARON LEA [US], et al);
 [Y]US2010034738  (GOLDENBERG DAVID M [US], et al);
 [Y]US2010221187  (LIEBERBURG IVAN [US], et al);
 [Y]US2011071054  (SIMARD JOHN [US]);
 [T]US2011305631  (GOVINDAN SERENGULAM V [US], et al);
by applicantUS4036945
 US4331647
 US4699784
 US4704692
 US4824659
 US4863713
 US4946778
 US5057313
 US5229275
 US5256395
 US5443953
 US5487892
 US5525338
 US5567610
 US5587459
 US5633425
 US5632968
 US5677136
 US5677427
 US5686072
 US5697902
 US5716595
 US5736119
 US5776456
 US5789554
 US5798229
 US5814440
 US5831034
 US5874540
 US5911989
 US5922302
 US6071490
 US6077499
 US6090381
 US6096289
 US6107090
 US6120767
 US6129914
 US6183744
 US6187287
 US6187284
 US6254868
 US6294173
 US6306393
 US6331175
 US6340571
 US6340459
 US6344198
 US6346246
 US6355481
 US6355444
 US6355245
 US6355244
 US6359126
 US6372215
 US6376654
 US6383759
 US6383484
 US6387350
 US6395276
 US6395274
 US6403770
 US6403091
 US6406694
 US6413726
 US6419928
 US6432404
 US6432402
 US6441143
 US6444206
 US6451310
 US6455044
 US6455040
 US6458356
 US6461823
 US6465173
 US6468531
 US6468529
 US6472511
 US6479247
 US6482598
 US6482408
 US6488930
 US6491915
 US6511665
 US6518404
 US6521227
 US6528625
 US6528269
 US6534058
 US6545130
 US6544749
 US6548275
 US6562618
 US6566076
 US6572856
 US6576745
 US6592868
 US6596852
 US6605441
 US6605279
 US6610833
 US6610294
 US6630144
 US6635482
 US6645493
 US6653104
 US6652852
 US6673344
 US6676924
 US6682737
 US6682736
 US6682734
 US6689607
 US6689362
 US6689355
 US6693176
 US6692908
 US6709653
 US6716966
 US6720155
 US6730307
 US6730300
 US6733981
 US6743898
 US6764688
 US6764681
 US6764679
 US6767711
 US6770450
 US6783758
 US6793924
 US6812206
 US6824780
 US6824778
 US6835549
 US6835370
 US6838282
 US6861511
 US6861227
 US6861226
 US6864062
 US6867006
 US6872568
 US6875580
 US6878812
 US6881405
 US6884594
 US6887468
 US6887466
 US6893625
 US6899879
 US6899864
 US6905681
 US6916475
 US6919433
 US6919078
 US6921645
 US6921533
 US6926893
 US6939547
 US6943020
 US6946129
 US6949244
 US6951924
 US6953675
 US6956107
 US6962981
 US6962813
 US6962702
 US6965018
 US6964854
 US2005271671
 US6974863
 US6989241
 US6994976
 US6994852
 US6998468
 US7001598
 US7012133
 US7011812
 US7022828
 US7033572
 US7038018
 US7037498
 US7041803
 US7041802
 US7041293
 US7045132
 US7049060
 US7052872
 US7056509
 US7060802
 US7074403
 US7074405
 US2006153846
 US7109304
 US7138103
 US7147856
 US7148342
 US7151164
 US7217797
 US7230084
 US7238785
 US7238786
 US7251164
 US7256004
 US7259240
 WO2007103469
 US7282567
 US7300655
 US7300644
 US7312318
 US7387773
 US7387772
 US7435803
 WO2008137915
 US7517523
 US7521056
 US7527787
 US7531327
 US7534866
 US7534431
 US7537930
 US7541440
 US7541453
 US7550143
 US7550572
 US7576196
 US7576197
 US7579457
 US7582746
 US7585491
 US7592443
 US7608425
 US7608707
 WO2009130575
 US7612180
 US7632938
 US7632939
 US7635771
 US7638621
 US7642239
 US7642349
 US7666400
 US7696344
 US7772373
 US7781575
 US7785880
 US7795421
 US7858070
 US7871622
 US7901680
 US7906121
 US7906118
 US7910702
 US7919087
 US7931903
 US20050193865
 US20050202666
 US20070983372
 US20080745692
 US20100772645
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.